Literature DB >> 17978284

Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.

Christiane Robbins1, Jada Benn Torres, Stanley Hooker, Carolina Bonilla, Wenndy Hernandez, Angela Candreva, Chiledum Ahaghotu, Rick Kittles, John Carpten.   

Abstract

Prostate cancer is a common complex disease that disproportionately affects men of African descent. Recently, several different common variants on chromosome 8q24 have been shown to be associated with prostate cancer in multiple studies and ethnic groups. The objective of this study was to confirm the association of 8q24 markers with prostate cancer in African Americans. We genotyped 24 markers along 8q24 and 80 unlinked ancestry informative markers in a hospital-based case-control sample of 1057 African American men (490 prostate cancer cases and 567 controls). Association analyses of 8q24 markers with prostate cancer risk were adjusted for both global and local 8q24 admixture stratification using estimates from ancestry informative markers. We report that rs7008482, which maps to the 8q24.13 region, is an additional independent prostate cancer risk variant (P = 5 x 10(-4)), and we also replicate the association of rs16901979 with prostate cancer (P = 0.002). Other published risk variants in the region such as rs1447295 and rs6983267 showed a similar direction and magnitude of effect, but were not significant in our population. Both rs7008482 and rs16901979 independently predicted risk and remained significant (P < 0.001) after controlling for each other. Our data combined with additional replications of 8q24 markers provide compelling support for multiple regions of risk for prostate cancer on 8q24.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978284      PMCID: PMC2099580          DOI: 10.1101/gr.6782707

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  21 in total

1.  Multiple regions within 8q24 independently affect risk for prostate cancer.

Authors:  Christopher A Haiman; Nick Patterson; Matthew L Freedman; Simon R Myers; Malcolm C Pike; Alicja Waliszewska; Julie Neubauer; Arti Tandon; Christine Schirmer; Gavin J McDonald; Steven C Greenway; Daniel O Stram; Loic Le Marchand; Laurence N Kolonel; Melissa Frasco; David Wong; Loreall C Pooler; Kristin Ardlie; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Esther M John; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

2.  Multiple prostate cancer risk variants on 8q24.

Authors:  John S Witte
Journal:  Nat Genet       Date:  2007-05       Impact factor: 38.330

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array.

Authors:  Wennuan Liu; Baoli Chang; Jurga Sauvageot; Latchezar Dimitrov; Marta Gielzak; Tao Li; Guifang Yan; Jishan Sun; Jielin Sun; Tamara S Adams; Aubrey R Turner; Jin Woo Kim; Deborah A Meyers; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Genes Chromosomes Cancer       Date:  2006-11       Impact factor: 5.006

5.  The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.

Authors:  Gianluca Severi; Vanessa M Hayes; Emma J D Padilla; Dallas R English; Melissa C Southey; Robert L Sutherland; John L Hopper; Graham G Giles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

6.  Cellular expression, localization and interactions of the product of the human MOST-1 gene associated with breast and prostate cancers.

Authors:  Jeanne M M Tan; Vincent T K Chow
Journal:  Int J Oncol       Date:  2007-01       Impact factor: 5.650

7.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

8.  The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.

Authors:  J M M Tan; E P C Tock; V T K Chow
Journal:  Mol Pathol       Date:  2003-04

9.  Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization.

Authors:  A El Gedaily; L Bubendorf; N Willi; W Fu; J Richter; H Moch; M J Mihatsch; G Sauter; T C Gasser
Journal:  Prostate       Date:  2001-02-15       Impact factor: 4.104

10.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

View more
  72 in total

1.  Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.

Authors:  Sarah M Troutman; Tristan M Sissung; Cheryl D Cropp; David J Venzon; Shawn D Spencer; Bamidele A Adesunloye; Xuan Huang; Fatima H Karzai; Douglas K Price; William D Figg
Journal:  Oncologist       Date:  2012-03-01

2.  Inferring genetic ancestry: opportunities, challenges, and implications.

Authors:  Charmaine D Royal; John Novembre; Stephanie M Fullerton; David B Goldstein; Jeffrey C Long; Michael J Bamshad; Andrew G Clark
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

3.  Race as a social construct in head and neck cancer outcomes.

Authors:  Maria J Worsham; George Divine; Rick A Kittles
Journal:  Otolaryngol Head Neck Surg       Date:  2011-02-04       Impact factor: 3.497

4.  Multiple loci on 8q24 associated with prostate cancer susceptibility.

Authors:  Ali Amin Al Olama; Zsofia Kote-Jarai; Graham G Giles; Michelle Guy; Jonathan Morrison; Gianluca Severi; Daniel A Leongamornlert; Malgorzata Tymrakiewicz; Sameer Jhavar; Ed Saunders; John L Hopper; Melissa C Southey; Kenneth R Muir; Dallas R English; David P Dearnaley; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Rosemary A Wilkinson; Emma Sawyer; Artitaya Lophatananon; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin Cooper; Jenny L Donovan; Freddie C Hamdy; David E Neal; Rosalind A Eeles; Douglas F Easton
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

Review 5.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  Cansu Karakas; Cassie Wang; Fangming Deng; Hongying Huang; Dongwen Wang; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

6.  Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.

Authors:  Haiyang Guo; Musaddeque Ahmed; Fan Zhang; Cindy Q Yao; SiDe Li; Yi Liang; Junjie Hua; Fraser Soares; Yifei Sun; Jens Langstein; Yuchen Li; Christine Poon; Swneke D Bailey; Kinjal Desai; Teng Fei; Qiyuan Li; Dorota H Sendorek; Michael Fraser; John R Prensner; Trevor J Pugh; Mark Pomerantz; Robert G Bristow; Mathieu Lupien; Felix Y Feng; Paul C Boutros; Matthew L Freedman; Martin J Walsh; Housheng Hansen He
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

7.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Authors:  Sungshim Lani Park; Shen-Chih Chang; Lin Cai; Carlos Cordon-Cardo; Bao-Guo Ding; Sander Greenland; Shehnaz K Hussain; Qingwu Jiang; Simin Liu; Ming-Lan Lu; Jenny T Mao; Hal Morgenstern; Li-Na Mu; Leslie J Ng; Allan Pantuck; Jianyu Rao; Victor E Reuter; Donald P Tashkin; Nai-Chieh Y You; Can-Qing Yu; Shun-Zhang Yu; Jin-Kou Zhao; Arie Belldegrun; Zuo-Feng Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.

Authors:  Eric J Whitman; Mark Pomerantz; Yongmei Chen; Michael M Chamberlin; Bungo Furusato; Chunling Gao; Amina Ali; Lakshmi Ravindranath; Albert Dobi; Isabell A Sesterhenn; Isabell A Sestrehenn; David G McLeod; Shiv Srivastava; Matthew Freedman; Gyorgy Petrovics
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

10.  Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.

Authors:  S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Zhengrong Gao; Pär Stattin; Lina D Purcell; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Jan Adolfsson; Jan-Erik Johansson; Aubrey R Turner; Tamara S Adams; Wennuan Liu; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.